Welcome to our dedicated page for Sun Life Finl news (Ticker: SLF), a resource for investors and traders seeking the latest updates and insights on Sun Life Finl stock.
Sun Life Financial Inc. reports recurring developments across its international financial services business, including insurance, wealth, health and asset management solutions for individual and institutional clients. Company updates commonly cover quarterly results, assets under management, segment trends in Canada, the U.S., Asia and asset management, and the performance of Sun Life Asset Management and U.S. Health & Risk Solutions.
News also includes capital actions such as common and preferred share dividends, dividend reinvestment plan mechanics, director elections, annual meeting voting results, executive and governance matters, and partnership activity tied to health and community programs. Sun Life trades under SLF on the Toronto, New York and Philippine stock exchanges.
Sun Life U.S. has expanded its Health Navigator service to medium and small group employers, aiming to help more workers access healthcare services. Health Navigator, powered by PinnacleCare, offers personalized guidance through dedicated Care Advisors, helping members get the right medical diagnoses, providers, and treatments.
Key benefits for employees include:
- Access to expert medical opinions
- Expedited appointments with qualified specialists
- 94% overall member satisfaction
- Access to Health 360, a digital app with various health and well-being tools
For employers, Health Navigator can potentially influence health outcomes and reduce costs, with data showing an average annual savings of $13,000 in healthcare costs per treatment outcome. The service is available to covered employees and their dependents, with additional options like Bill Resolve and Extended Care.
Sun Life has selected Hinge Health as its preferred digital musculoskeletal (MSK) solution for members, aiming to improve healthcare outcomes and contain costs. This partnership addresses the rising trend of MSK-related healthcare costs, which ranked as the fifth highest cost claims between 2020-2023 according to Sun Life's report. Hinge Health will provide personalized programs with access to physical therapists, health coaches, and orthopedic surgeons, utilizing technology and expert clinicians to help members manage pain and reduce dependence on medication.
Additionally, Sun Life has launched Health 360, a new mobile and web-based app designed to connect members directly with health capabilities, including Hinge Health services, Health Navigator Care Advisors, and various health and well-being tools.
SLC Management, managing $277 billion in institutional fixed income and alternative assets, has launched the SLC Global Insurance Group. This new division aims to provide specialized investment solutions for the world's leading insurance companies. The group leverages the resources and expertise of SLC Management's subsidiaries, including SLC Fixed Income, BGO, Crescent Capital Group, and InfraRed Capital Partners. With over 260 insurance clients and $152 billion in assets under management (AUM), the group offers strategies for income enhancement, risk mitigation, and liquidity management. Key appointments include John Cassedy as Managing Director for Insurance Business Development effective July 1, along with the recent additions of Amanda Geuss and Olivia Barden. The initiative is seen as a natural extension of SLC's longstanding work in the insurance sector.
Crescent Capital Group has announced significant leadership changes. Managing Director and Head of Private Credit Christopher Wright has been promoted to President, recognizing his 23 years of service and expertise. Chief Operating Officer Joseph Viola has been named Chairman of the Operating Committee, responsible for critical day-to-day operations. Additionally, Jason Breaux, CEO of Crescent Capital BDC, has been appointed to the Operating Committee. These changes aim to support Crescent's growth and operational efficiency.
Wright, Viola, and Breaux each bring extensive experience to their new roles, reflecting Crescent's strategic focus on leadership and operational excellence. The leadership team, including Co-Founders Mark Attanasio and Jean-Marc Chapus, will continue to steer Crescent’s growth and maintain its reputation in alternative credit investing.
Sun Life (TSX: SLF) (NYSE: SLF) announced its plan to redeem its $750 million Series 2019-1 Subordinated Unsecured 2.38% Fixed/Floating Debentures on August 13, 2024. The redemption, in accordance with the debentures' terms, will be funded from existing cash and liquid assets. Upon redemption, interest will cease to accrue and holders will only be entitled to receive the redemption price, which includes the principal amount and accrued interest.
Sun Life U.S. has received the Wage Equity Impact Award from the Boston Women's Workforce Council (BWWC) for its efforts in closing gender and racial pay gaps. The award will be presented today at Boston University's Center for Computing and Dynamics. Sun Life has confirmed no systemic pay gaps for women or professionals of color within the organization through extensive research. The company's commitment to wage equity started in 2016 when it signed the BWWC's Boston Women's Talent Compact. Recent BWWC data shows women now earn 79 cents for every dollar earned by men, an improvement from a 30-cent gap in 2021. Sun Life has been recognized as a Forbes Best Employer for Diversity and is listed on the Bloomberg Gender Equality Index. Globally, the company aims for gender parity at vice president levels and above by 2025.
Sun Life U.S. and DentaQuest have donated $50,000 to Dimock Center's new Cardiometabolic Clinic in Boston. This clinic aims to provide comprehensive care for patients suffering from hypertension, diabetes, and heart disease. The donation will support the clinic's operations for its pilot year. Dimock's program aligns with Sun Life's and DentaQuest's goals of improving access to health care, particularly for moderate- and high-risk patients. The clinic will also collaborate with Dimock's dental department to integrate medical and dental care, addressing health inequities in marginalized populations.
Sun Life U.S. and DentaQuest have a history of supporting health initiatives that prioritize medical-dental integration. This contribution is part of their ongoing efforts to foster holistic health solutions and improve health outcomes.
Sun Life U.S. has expanded its partnership with Goodpath to offer virtual whole-person care to its employer clients. This new benefit covers both physical and mental health, including unlimited therapy sessions, aiming to reduce employee absences and extended leaves. Goodpath's services encompass mental health, musculoskeletal conditions, digestive issues, sleep concerns, and cancer survivorship. Members receive customized care plans, health coaching, and monthly care kits delivered to their homes. Early results indicate significant reductions in pain, anxiety, and depression among participants. This expansion aims to enhance employee health and lower healthcare costs.
Sun Life U.S. has been recognized as a Top Place to Work by the Milwaukee Journal Sentinel, ranking sixth in the largest companies category. This marks its first recognition in Milwaukee, following its 2022 acquisition of DentaQuest. The award is based on employee feedback and company culture. Sun Life U.S. has also been recognized by the Boston Globe, Hartford Courant, Baltimore Sun, and USA Today for workplace excellence. The company emphasizes a supportive, flexible work environment with multiple business hubs and a hybrid work model. Sun Life U.S. has also received several other commendations, including Forbes America's Best Large Employers and TIME Top Companies for Future Leaders.
Sun Life has published its annual High-Cost Claims and Injectable Drug Trends Analysis report, covering 60,000 stop-loss claims from 2019 to 2022. The report indicates that 87% of self-funded employers encountered at least one high-cost claim. Cardiovascular disease has risen to the second-highest claim, overtaking blood cancers, with a 33% increase in average costs since 2020. Malignant neoplasms remain the highest-paid claims category.
Key findings include a significant rise in newborn/infant care claims, totaling $11.5 million for the highest claim, and an increase in multi-million-dollar claims. Orthopedics/musculoskeletal conditions show the highest number of high-cost claims among top conditions. The top 10 injectable drugs, led by Keytruda, accounted for over $10 million each in total spend.
Join Sun Life's webinar on June 5 for further insights.